Nisa Investment Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,165
Closed -$113K 2064
2019
Q3
$113K Buy
1,165
+1,010
+652% +$101K ﹤0.01% 1435
2019
Q2
$16K Hold
155
﹤0.01% 1644
2019
Q1
$18K Hold
155
﹤0.01% 1638
2018
Q4
$6K Hold
155
﹤0.01% 1792
2018
Q3
$8K Sell
155
-50
-24% -$3.42K ﹤0.01% 1800
2018
Q2
$17K Buy
205
+70
+52% +$5.4K ﹤0.01% 1571
2018
Q1
$9K Sell
135
-75
-36% -$4.33K ﹤0.01% 1699
2017
Q4
$11K Sell
210
-500
-70% -$35.9K ﹤0.01% 1730
2017
Q3
$63K Hold
710
﹤0.01% 1432
2017
Q2
$42K Sell
710
-450
-39% -$25.1K ﹤0.01% 1417
2017
Q1
$62K Sell
1,160
-140
-11% -$8.31K ﹤0.01% 1419
2016
Q4
$65K Buy
1,300
+300
+30% +$16.1K ﹤0.01% 1401
2016
Q3
$60K Buy
+1,000
New +$57.6K ﹤0.01% 1389

Nisa Investment Advisors's ONCE Position: Q4 2019 in Review

Nisa Investment Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 1,165 shares — an estimated $113K sold.

Nisa Investment Advisors first reported a position in ONCE in Q3 2016 and held it in 13 quarters. The position peaked at $113K in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Nisa Investment Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,165 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $113K.
  • Nisa Investment Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2016 and held it in 13 quarters.
  • Nisa Investment Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $113K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Nisa Investment Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.